By in vivo macrophage depletion and adoptive transfer approach, we further proved that the M2-polarized SNX10−/− macrophages could significantly ameliorated DSS-induced colitis, suggesting that manipulating macrophage polarization targeting SNX10 may be an attractive new strategy for IBD treatment. This evidence concerns the gene SNX10 and inflammatory bowel disease.